메뉴 건너뛰기




Volumn 63, Issue 2, 2014, Pages 413-419

Metabolic syndrome and risk of incident peripheral artery disease: The cardiovascular health study

Author keywords

cohort studies; inflammation; metabolic syndrome; peripheral artery disease

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

EID: 84892925036     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01925     Document Type: Article
Times cited : (51)

References (31)
  • 1
    • 0037126526 scopus 로고    scopus 로고
    • Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults adult treatment panel iii) final report
    • Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation. 2002;106:3143-3421.
    • (2002) Circulation , vol.106 , pp. 3143-3421
  • 2
    • 0842277242 scopus 로고    scopus 로고
    • Definition of metabolic syndrome: Report of the National Heart Lung and Blood Institute/American Heart Association conference on scientific issues related to definition
    • American Heart Association National Heart Lung Blood Institute
    • Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438.
    • (2004) Circulation , vol.109 , pp. 433-438
    • Grundy, S.M.1    Brewer Jr., H.B.2    Cleeman, J.I.3    Smith Jr., S.C.4    Lenfant, C.5
  • 3
    • 27444443876 scopus 로고    scopus 로고
    • Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
    • American Heart Association National Heart Lung Blood Institute
    • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-2752.
    • (2005) Circulation , vol.112 , pp. 2735-2752
    • Grundy, S.M.1    Cleeman, J.I.2    Daniels, S.R.3    Donato, K.A.4    Eckel, R.H.5    Franklin, B.A.6    Gordon, D.J.7    Krauss, R.M.8    Savage, P.J.9    Smith Jr., S.C.10    Spertus, J.A.11    Costa, F.12
  • 4
    • 4444222221 scopus 로고    scopus 로고
    • Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults
    • Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245-1250.
    • (2004) Circulation , vol.110 , pp. 1245-1250
    • Malik, S.1    Wong, N.D.2    Franklin, S.S.3    Kamath, T.V.4    L'Italien, G.J.5    Pio, J.R.6    Williams, G.R.7
  • 5
    • 33846365989 scopus 로고    scopus 로고
    • Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies
    • Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403-414.
    • (2007) J Am Coll Cardiol , vol.49 , pp. 403-414
    • Gami, A.S.1    Witt, B.J.2    Howard, D.E.3    Erwin, P.J.4    Gami, L.A.5    Somers, V.K.6    Montori, V.M.7
  • 6
    • 0037469255 scopus 로고    scopus 로고
    • C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women
    • Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107:391-397.
    • (2003) Circulation , vol.107 , pp. 391-397
    • Ridker, P.M.1    Buring, J.E.2    Cook, N.R.3    Rifai, N.4
  • 8
    • 62749091051 scopus 로고    scopus 로고
    • Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study
    • Wild SH, Byrne CD, Tzoulaki I, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study. Atherosclerosis. 2009;203:604-609.
    • (2009) Atherosclerosis , vol.203 , pp. 604-609
    • Wild, S.H.1    Byrne, C.D.2    Tzoulaki, I.3    Lee, A.J.4    Rumley, A.5    Lowe, G.D.6    Fowkes, F.G.7
  • 9
    • 70349656512 scopus 로고    scopus 로고
    • Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: A prospective study
    • Conen D, Rexrode KM, Creager MA, Ridker PM, Pradhan AD. Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study. Circulation. 2009;120:1041-1047.
    • (2009) Circulation , vol.120 , pp. 1041-1047
    • Conen, D.1    Rexrode, K.M.2    Creager, M.A.3    Ridker, P.M.4    Pradhan, A.D.5
  • 10
    • 33846404160 scopus 로고    scopus 로고
    • Assessment by cardiovascular magnetic resonance, electron beam computed tomography, and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata
    • Kathiresan S, Larson MG, Keyes MJ, Polak JF, Wolf PA, D'Agostino RB, Jaffer FA, Clouse ME, Levy D, Manning WJ, O'Donnell CJ. Assessment by cardiovascular magnetic resonance, electron beam computed tomography, and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata. Am J Cardiol. 2007;99:310-314.
    • (2007) Am J Cardiol , vol.99 , pp. 310-314
    • Kathiresan, S.1    Larson, M.G.2    Keyes, M.J.3    Polak, J.F.4    Wolf, P.A.5    D'Agostino, R.B.6    Jaffer, F.A.7    Clouse, M.E.8    Levy, D.9    Manning, W.J.10    O'Donnell, C.J.11
  • 11
    • 0348222671 scopus 로고    scopus 로고
    • Inflammation: The link between insulin resistance, obesity and diabetes
    • Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4-7.
    • (2004) Trends Immunol , vol.25 , pp. 4-7
    • Dandona, P.1    Aljada, A.2    Bandyopadhyay, A.3
  • 12
    • 15444366991 scopus 로고    scopus 로고
    • Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation
    • Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111:1448-1454.
    • (2005) Circulation , vol.111 , pp. 1448-1454
    • Dandona, P.1    Aljada, A.2    Chaudhuri, A.3    Mohanty, P.4    Garg, R.5
  • 13
    • 20444388705 scopus 로고    scopus 로고
    • The metabolic syndrome and insulin resistance: Relationship to haemostatic and inflammatory markers in older non-diabetic men
    • Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis. 2005;181:101-108.
    • (2005) Atherosclerosis , vol.181 , pp. 101-108
    • Wannamethee, S.G.1    Lowe, G.D.2    Shaper, A.G.3    Rumley, A.4    Lennon, L.5    Whincup, P.H.6
  • 14
    • 2942670689 scopus 로고    scopus 로고
    • Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?
    • Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818-2825.
    • (2004) Circulation , vol.109 , pp. 2818-2825
    • Ridker, P.M.1    Wilson, P.W.2    Grundy, S.M.3
  • 17
    • 70350245011 scopus 로고    scopus 로고
    • Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; And International Association for the Study of Obesity
    • Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
    • (2009) Circulation , vol.120 , pp. 1640-1645
    • Alberti, K.G.1    Eckel, R.H.2    Grundy, S.M.3    Zimmet, P.Z.4    Cleeman, J.I.5    Donato, K.A.6    Fruchart, J.C.7    James, W.P.8    Loria, C.M.9    Smith Jr., S.C.10
  • 18
  • 19
    • 0037469232 scopus 로고    scopus 로고
    • Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association
    • Centers for Disease Control and Prevention; American Heart Association
    • Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
    • (2003) Circulation , vol.107 , pp. 499-511
    • Pearson, T.A.1    Mensah, G.A.2    Alexander, R.W.3    Anderson, J.L.4    Cannon Iii., R.O.5    Criqui, M.6    Fadl, Y.Y.7    Fortmann, S.P.8    Hong, Y.9    Myers, G.L.10    Rifai, N.11    Smith Jr., S.C.12    Taubert, K.13    Tracy, R.P.14    Vinicor, F.15
  • 21
    • 0027312622 scopus 로고
    • Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index
    • Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA. 1993;270:487-489.
    • (1993) JAMA , vol.270 , pp. 487-489
    • Newman, A.B.1    Sutton-Tyrrell, K.2    Vogt, M.T.3    Kuller, L.H.4
  • 23
    • 55549107191 scopus 로고    scopus 로고
    • Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality
    • Criqui MH, Ninomiya JK, Wingard DL, Ji M, Fronek A. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol. 2008;52:1736-1742.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 1736-1742
    • Criqui, M.H.1    Ninomiya, J.K.2    Wingard, D.L.3    Ji, M.4    Fronek, A.5
  • 27
    • 47049084052 scopus 로고    scopus 로고
    • Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: A meta-analysis
    • Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300:197-208.
    • (2008) JAMA , vol.300 , pp. 197-208
    • Fowkes, F.G.1    Murray, G.D.2    Butcher, I.3
  • 28
    • 0035897688 scopus 로고    scopus 로고
    • Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
    • Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481-2485.
    • (2001) JAMA , vol.285 , pp. 2481-2485
    • Ridker, P.M.1    Stampfer, M.J.2    Rifai, N.3
  • 29
    • 33846968816 scopus 로고    scopus 로고
    • Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study
    • Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study. Eur Heart J. 2007;28:354-362.
    • (2007) Eur Heart J , vol.28 , pp. 354-362
    • Tzoulaki, I.1    Murray, G.D.2    Lee, A.J.3    Rumley, A.4    Lowe, G.D.5    Fowkes, F.G.6
  • 30
    • 0027199099 scopus 로고
    • Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group
    • Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, Wolfson SK. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993;88:837-845.
    • (1993) Circulation , vol.88 , pp. 837-845
    • Newman, A.B.1    Siscovick, D.S.2    Manolio, T.A.3    Polak, J.4    Fried, L.P.5    Borhani, N.O.6    Wolfson, S.K.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.